Aarhus University Seal / Aarhus Universitets segl

Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 cluster

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperLetterResearchpeer-review

  • Guy Wayne Novotny, Department of Growth & Reproduction, Rigshospitalet, Denmark
  • Stine Sonne, Department of Growth & Reproduction, Rigshospitalet, Denmark
  • Jens Erik Nielsen, Denmark
  • Søren Peter Jonstrup, Denmark
  • Martin Andreas Hansen, Denmark
  • N E Skakkebaek, Department of Growth & Reproduction, Rigshospitalet, Denmark
  • Ewa Rajpert-De Meyts, Department of Growth & Reproduction, Rigshospitalet, Denmark
  • Jørgen Kjems
  • H Leffers, Denmark
The E2F1 transcription factor is a key regulatory factor of both apoptosis and cell cycle progression, and depending on cellular context, can act as either an oncogene or a tumour suppressor. Consequently, gene mutations that lead to deregulation of E2F1 activity are detected in a majority of human cancers.1 Recently, an array study identified E2F1 as upregulated in human testis containing preinvasive carcinoma in situ (CIS) cells when compared with normal human testis.2 Apparently, supporting this, an E2F1 overexpressing mouse demonstrated generation of CIS-like cells in testis that were otherwise atrophying owing to massive E2F1-induced apoptosis of germ cells
Original languageEnglish
JournalCell Death and Differentiation
Pages (from-to)879-882
Number of pages4
Publication statusPublished - 2007

    Research areas

  • Animals, Carcinoma in Situ, Cell Cycle Proteins, E2F1 Transcription Factor, Gene Expression Regulation, Germ Cells, Humans, Immunohistochemistry, In Situ Hybridization, Male, Mice, MicroRNAs, Protein Biosynthesis, RNA Processing, Post-Transcriptional, RNA, Messenger, Testis

See relations at Aarhus University Citationformats

ID: 44942240